Biocon has enclosed Company Statement with regards to ‘Biocon Biologics Receives Positive CHMP Opinions for Biosimilar Denosumab in Europe’. This information will also be available on the website of the Company at www.biocon.com
The above information is a part of company’s filings submitted to BSE.